These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32553718)

  • 1. Influence of pneumococcal vaccination on the hospitalization of healthy pediatric patients due to typical Community-Acquired Pneumonia.
    Valdivielso Martínez AI; Ramos Fernández JM; Pérez Frías J; Moreno Pérez D
    Int J Infect Dis; 2020 Sep; 98():194-199. PubMed ID: 32553718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study.
    Liese JG; Schoen C; van der Linden M; Lehmann L; Goettler D; Keller S; Maier A; Segerer F; Rose MA; Streng A
    Clin Microbiol Infect; 2019 Jul; 25(7):857-864. PubMed ID: 30395932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
    van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ
    Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity.
    Sterky E; Bennet R; Lindstrand A; Eriksson M; Nilsson A
    Eur J Pediatr; 2017 Mar; 176(3):337-342. PubMed ID: 28070670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.
    Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
    Azzari C; Serranti D; Nieddu F; Moriondo M; Casini A; Lodi L; de Benedictis FM; De Vitis E; Cavone F; Cortimiglia M; Indolfi G; Lombardi E; Carloni I; Cutrera R; Lucenteforte E; Resti M; Ricci S
    Vaccine; 2019 May; 37(20):2704-2711. PubMed ID: 30981627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
    Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
    Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal Vaccination and Pneumonia Associated With Pleural Effusion in a Pediatric Population.
    Bernaola E; Gil F; Herranz M; Gil-Setas A; Guevara M; Castilla J
    Pediatr Infect Dis J; 2018 Apr; 37(4):e87-e92. PubMed ID: 28938258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
    Pírez MC; Algorta G; Cedrés A; Sobrero H; Varela A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2011 Aug; 30(8):669-74. PubMed ID: 21407145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
    How CH; Phua See Chun P; Shafi F; Jakes RW
    BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
    Ouldali N; Levy C; Minodier P; Morin L; Biscardi S; Aurel M; Dubos F; Dommergues MA; Mezgueldi E; Levieux K; Madhi F; Hees L; Craiu I; Gras Le Guen C; Launay E; Zenkhri F; Lorrot M; Gillet Y; Béchet S; Hau I; Martinot A; Varon E; Angoulvant F; Cohen R
    JAMA Pediatr; 2019 Apr; 173(4):362-370. PubMed ID: 30715140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis.
    Gajewska M; Goryński P; Paradowska-Stankiewicz I; Lewtak K; Piotrowicz M; Urban E; Cianciara D; Wysocki MJ; Książek A; Izurieta P
    Vaccine; 2020 Jan; 38(2):194-201. PubMed ID: 31653527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
    Li ST; Tancredi DJ
    Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children.
    Eichler N; Joseph L; Megged O; Goldberg S; Picard E
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):439-444. PubMed ID: 34997390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation.
    Madhi F; Levy C; Morin L; Minodier P; Dubos F; Zenkhri F; Dommergues MA; Mezgueldi E; Levieux K; ; Béchet S; Varon E; Cohen R;
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):474-477. PubMed ID: 30407519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.